"B7-1 Antigen" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				A costimulatory ligand membrane glycoprotein that contains a V2 type and C2 IMMUNOGLOBULIN DOMAIN and is expressed by ANTIGEN-PRESENTING CELLS. It binds to CTLA-4 ANTIGEN with high specificity and to CD28 ANTIGEN with low specificity. The interaction of CD80 with CD28 ANTIGEN provides a costimulatory signal to T-LYMPHOCYTES, while its interaction with CTLA-4 ANTIGEN may play a role in inducing PERIPHERAL TOLERANCE.
    
			
			
				
				
					
						| Descriptor ID | D018122 | 
					
						| MeSH Number(s) | D12.776.467.150.100 D12.776.543.095.100 D23.050.301.285.100 D23.529.168.100 | 
					
						| Concept/Terms | B7-1 AntigenB7-1 AntigenB7 1 AntigenCD80 AntigenCD80 AntigensB7-1 LigandB7 1 LigandLigand, B7-1B7-1 Costimulatory MoleculeB7 1 Costimulatory MoleculeCostimulatory Molecule, B7-1Antigen, B7-1Antigen, B7 1B-Cell Activation AntigenB Cell Activation AntigenAntigens, CD80
 | 
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "B7-1 Antigen".
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "B7-1 Antigen".
				
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "B7-1 Antigen" by people in this website by year, and whether "B7-1 Antigen" was a major or minor topic of these publications. 
				
					 
                    To see the data from this visualization as text, 
click here. 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 2004 | 0 | 1 | 1 | 
| 2006 | 0 | 1 | 1 | 
| 2007 | 0 | 1 | 1 | 
| 2010 | 0 | 1 | 1 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "B7-1 Antigen" by people in Profiles.
						
					
								- 
								CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance: response. Pediatr Nephrol. 2014 Aug; 29(8):1467-8. 
- 
								Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med. 2014 03 27; 370(13):1263-4. 
- 
								Role of podocyte B7-1 in diabetic nephropathy. J Am Soc Nephrol. 2014 Jul; 25(7):1415-29. 
- 
								Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med. 2013 Dec 19; 369(25):2416-23. 
- 
								Maximal 'CD80-uria' with minimal change. Kidney Int. 2010 Aug; 78(3):236-8. 
- 
								Soluble ions more than particulate cobalt-alloy implant debris induce monocyte costimulatory molecule expression and release of proinflammatory cytokines critical to metal-induced lymphocyte reactivity. J Biomed Mater Res A. 2010 Jun 15; 93(4):1312-21. 
- 
								Proteinuria: an enzymatic disease of the podocyte? Kidney Int. 2010 Apr; 77(7):571-80. 
- 
								PDL-1 upregulation on monocytes and T cells by HIV via type I interferon: restricted expression of type I interferon receptor by CCR5-expressing leukocytes. Clin Immunol. 2008 Oct; 129(1):132-44. 
- 
								Impaired CCR7 expression on plasmacytoid dendritic cells of HIV-infected children and adolescents with immunologic and virologic failure. J Acquir Immune Defic Syndr. 2007 Aug 15; 45(5):501-7. 
- 
								A whole blood assay to assess peripheral blood dendritic cell function in response to Toll-like receptor stimulation. J Immunol Methods. 2006 Mar 20; 310(1-2):86-99.